CD9-binding peptide (TFA)

• Description:

  CD9-binding peptide TFA is a CD9-binding peptide. CD9-binding peptide TFA inhibits the binding of EWI-2 to CD9. CD9-binding peptide TFA exhibits selective anti-migratory and anti-invasive activities against cancer cells. CD9-binding peptide TFA can be used for the study of cancer[1].

• UNSPSC:

  12352209

• Target:

  Others

• Related Pathways:

  Others

• Field of Research:

  Cancer

• Purity:

  99.02

• Smiles:

  OC([C@H](CC1=CN=CN1)NC([C@H](CC(C)C)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H](CCCNC(N)=N)NC([C@@H](NC([C@H](CO)NC([C@@H](N)CCCNC(N)=N)=O)=O)CC2=CN=CN2)=O)=O)=O)=O)=O)=O.O=C(O)C(F)(F)F.[x]

• Molecular Formula:

  C45H79N21O10.xC2HF3O2

• Molecular Weight:

  1074.24 (free base)

• References & Citations:

  [1]Suwatthanarak T, et al. Inhibition of cancer-cell migration by tetraspanin CD9-binding peptide. Chem Commun (Camb) . 2021 May 18;57 (40) :4906-4909.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported